Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 27, 2019
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
Tue, February 26, 2019
[ Tue, Feb 26th 2019
] - WOPRAI
[ Tue, Feb 26th 2019
] - WOPRAI
[ Tue, Feb 26th 2019
] - WOPRAI
Yaron Werber Initiated (BLUE) at Buy on, Feb 26th, 2019
Yaron Werber of Cowen & Co., Initiated "bluebird bio, Inc." (BLUE) at Buy on, Feb 26th, 2019.
Yaron has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Yaron's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $125 on, Wednesday, December 19th, 2018
These are the ratings of the 2 analyists that currently disagree with Yaron
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $161 on, Wednesday, January 23rd, 2019
- Michael Schmidt of "Leerink Swann" Initiated at Buy and Held Target at $145 on, Wednesday, November 28th, 2018
Similar Stocks and Investing Articles
[ Wed, Jan 23rd 2019
] - WOPRAI
[ Wed, Mar 21st 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Thu, Feb 22nd 2018
] - WOPRAI
[ Thu, Feb 22nd 2018
] - WOPRAI
[ Tue, Mar 01st 2016
] - WOPRAI
[ Wed, Feb 03rd 2016
] - WOPRAI
[ Wed, Jan 27th 2016
] - WOPRAI
[ Mon, Jan 11th 2016
] - WOPRAI